Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A3407 EVP-6124 hydrochlorideSummary: Alpha7 nAChR agonist
-
A3565 LX-1031Target: Tryptophan hydroxylases (TPH)Summary: TPH inhibitor
-
A3770 RJR-2403 oxalateSummary: Nicotinic receptor agonist
-
B3250 RJR-2403 hemioxalateSummary: Neuronal nicotinic receptor agonist
-
B1140 VareniclineSummary: α4β2 nAChRs antagonist
-
B1141 Varenicline HydrochlorideSummary: α4β2 nicotinic receptor agonist
-
C3592 Spinosyn ASummary: insect nicotinic acetylcholinesterase receptors (nAChRs) agonist and potent insecticide
-
C4619 DerquantelSummary: nicotinic acetylcholine receptor antagonist
-
B5591 SR 16584Summary: α3β4 nAChR antagonist
-
B5597 SEN 12333Summary: α7 nicotinic acetylcholine receptor (nAChR) agonist